The generic injectables market in Europe is expected to grow from US$ 17,827.88 million in 2021 to US$ 34,509.74 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2021 to 2028.
Innovator drugs are expensive owing to high investments made in the research & development of molecules; these drugs are specifically unaffordable for a large share of the population in developing countries. However, generic drugs are affordable and provide greater access to healthcare. Additionally, the generic drug’s average manufacturer prices (AMP) are 39% lower than the branded drug’s AMP. The facts mentioned above boost the demand and availability of generic injectables, thus driving more players into the generic injectables market. Further, low prices of generic injectables contribute to greater and more effective chronic illness treatments. Generic injectables such as insulin injections offer immediate solutions for such ailments, ensuring affordable treatments in developing countries.
Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Europe Generic Injectables Market Segmentation
The Europe generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Europe generic injectables market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany contributed a substantial share in 2020.
AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Europe generic injectables market are among the leading companies in the Europe generic injectables market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 17,827.88 Million |
| Market Size by 2028 | US$ 34,509.74 Million |
| CAGR (2021 - 2028) | 9.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Generic Injectables Market is valued at US$ 17,827.88 Million in 2021, it is projected to reach US$ 34,509.74 Million by 2028.
As per our report Europe Generic Injectables Market, the market size is valued at US$ 17,827.88 Million in 2021, projecting it to reach US$ 34,509.74 Million by 2028. This translates to a CAGR of approximately 9.9% during the forecast period.
The Europe Generic Injectables Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Generic Injectables Market report:
The Europe Generic Injectables Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Generic Injectables Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Generic Injectables Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For Europe Generic Injectables Market
